Sonoma Pharmaceuticals (SNOA) Other Operating Expenses (2015 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Other Operating Expenses of -$146000.0 for Q1 2026, down 214.06% year-over-year from $128000.0 in Q1 2025, and up 46.13% quarter-over-quarter from -$271000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Other Operating Expenses (2015 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Other Operating Expenses history runs 12 years deep, the most recent figure standing at -$146000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 214.06% year-over-year to -$146000.0; the TTM figure through Mar 2026 stood at -$958000.0 (down 219.3% YoY), while the FY2026 annual figure was -$958000.0, down 219.3% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$146000.0, up from -$271000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $387000.0 in Q3 2024, with the low at -$544000.0 in Q1 2022.
- The 5-year median for Other Operating Expenses is -$90000.0 (2023), against an average of -$96764.7.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses slumped 745.45% in 2022, then soared 530.0% in 2024.
- Sonoma Pharmaceuticals' Other Operating Expenses stood at -$71000.0 in 2022, then retreated by 11.27% to -$79000.0 in 2023, then surged by 241.77% to $112000.0 in 2024, then tumbled by 341.96% to -$271000.0 in 2025, then surged by 46.13% to -$146000.0 in 2026.
- Business Quant data shows SNOA's Other Operating Expenses at -$146000.0 in Q1 2026, -$271000.0 in Q4 2025, and -$394000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.14 Mn | -199,359.47 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -290,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -271,000.00 |
| Sep 30, 2025 | -394,000.00 |
| Jun 30, 2025 | -147,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Jun 30, 2023 | -211,000.00 |
| Mar 31, 2023 | -292,000.00 |
| Dec 31, 2022 | -71,000.00 |
| Sep 30, 2022 | -186,000.00 |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -544,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Sep 30, 2021 | 723,000.00 |